Rethinking ovarian cancer: recommendations for improving outcomesSebastian Vaughan, Frances R. Balkwill, Jermaine Coward et al.|Nature reviews. Cancer|2011Cited by 1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D.L. Bowtell, Frances R. Balkwill, Karen H. Lu et al.|Nature reviews. Cancer|2015Cited by 1.4k
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G.W. Verhaak, Matthew Meyerson, Pablo Tamayo et al.|Journal of Clinical Investigation|2012Cited by 591
A recurrent mutation in PALB2 in Finnish cancer familiesHannele Erkko, Robert Winqvist, Bing Xia et al.|Nature|2007Cited by 461
Ovarian Cancer Pathogenesis: A Model in EvolutionAlison M. Karst, Ronny Drapkin|Journal of Oncology|2009Cited by 294